148 related articles for article (PubMed ID: 35748228)
1. Epigenetic Silencing of CHOP Expression by the Histone Methyltransferase EHMT1 Regulates Apoptosis in Colorectal Cancer Cells.
Kim K; Ryu TY; Lee J; Son MY; Kim DS; Kim SK; Cho HS
Mol Cells; 2022 Sep; 45(9):622-630. PubMed ID: 35748228
[TBL] [Abstract][Full Text] [Related]
2. Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors.
Bamberg LV; Heigwer F; Wandmacher AM; Singh A; Betge J; Rindtorff N; Werner J; Josten J; Skabkina OV; Hinsenkamp I; Erdmann G; Röcken C; Ebert MP; Burgermeister E; Zhan T; Boutros M
Int J Cancer; 2022 Nov; 151(9):1586-1601. PubMed ID: 35666536
[TBL] [Abstract][Full Text] [Related]
3. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
4. EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression.
Lee J; Kim K; Ryu TY; Jung CR; Lee MS; Lim JH; Park K; Kim DS; Son MY; Hamamoto R; Cho HS
Mol Oncol; 2021 Nov; 15(11):2989-3002. PubMed ID: 34214254
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying the effects of the small molecule AMC-04 on apoptosis: Roles of the activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway.
Kim SY; Hwang S; Choi MK; Park S; Nam KY; Kim I
Chem Biol Interact; 2020 Dec; 332():109277. PubMed ID: 33007289
[TBL] [Abstract][Full Text] [Related]
7. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.
Zheng Y; Liu A; Wang ZJ; Cao Q; Wang W; Lin L; Ma K; Zhang F; Wei J; Matas E; Cheng J; Chen GJ; Wang X; Yan Z
Brain; 2019 Mar; 142(3):787-807. PubMed ID: 30668640
[TBL] [Abstract][Full Text] [Related]
9. Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer.
Zhao LH; Li Q; Huang ZJ; Sun MX; Lu JJ; Zhang XH; Li G; Wu F
Cell Death Dis; 2021 Oct; 12(11):974. PubMed ID: 34671018
[TBL] [Abstract][Full Text] [Related]
10. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
[TBL] [Abstract][Full Text] [Related]
11. Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein.
Hwang S; Kim S; Kim K; Yeom J; Park S; Kim I
BMB Rep; 2020 Nov; 53(11):576-581. PubMed ID: 32684241
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
[TBL] [Abstract][Full Text] [Related]
13. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
[TBL] [Abstract][Full Text] [Related]
14. Histone Methyltransferases G9a/
Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
[TBL] [Abstract][Full Text] [Related]
15. Euchromatic histone lysine methyltransferase 1 regulates cancer development in human gastric cancer by regulating E-cadherin.
Yang Y; Shen J; Yan D; Yuan B; Zhang S; Wei J; Du T
Oncol Lett; 2018 Jun; 15(6):9480-9486. PubMed ID: 29844834
[TBL] [Abstract][Full Text] [Related]
16. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
17. De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a.
Vinson DA; Stephens KE; O'Meally RN; Bhat S; Dancy BCR; Cole RN; Yegnasubramanian S; Taverna SD
Epigenetics Chromatin; 2022 Nov; 15(1):36. PubMed ID: 36411491
[TBL] [Abstract][Full Text] [Related]
18. Holocarboxylase synthetase interacts physically with euchromatic histone-lysine N-methyltransferase, linking histone biotinylation with methylation events.
Li Y; Hassan YI; Moriyama H; Zempleni J
J Nutr Biochem; 2013 Aug; 24(8):1446-52. PubMed ID: 23337344
[TBL] [Abstract][Full Text] [Related]
19. PERK activation by CCT020312 chemosensitizes colorectal cancer through inducing apoptosis regulated by ER stress.
Lei Y; He L; Yan C; Wang Y; Lv G
Biochem Biophys Res Commun; 2021 Jun; 557():316-322. PubMed ID: 33894420
[TBL] [Abstract][Full Text] [Related]
20. Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
Besschetnova A; Han W; Liu M; Gao Y; Li M; Wang Z; Labaf M; Patalano S; Venkataramani K; Muriph RE; Macoska JA; Siegfried KR; Evans J; Balk SP; Gao S; Han D; Cai C
Cancer Res Commun; 2023 Aug; 3(8):1716-1730. PubMed ID: 37663929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
